Viewing Study NCT02331368


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-02-03 @ 3:24 AM
Study NCT ID: NCT02331368
Status: COMPLETED
Last Update Posted: 2018-07-27
First Post: 2015-01-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma
Sponsor: University of Michigan Rogel Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None Anti-PD-1 View
None Pembrolizumab View
None Post-transplant View
None Maintenance View